EAK proteins: novel conserved regulators of C. elegans lifespan.
FoxO transcription factors (TFs) extend lifespan in invertebrates and may participate in the control of human longevity. The role of FoxO TFs in lifespan regulation has been studied most extensively inC. elegans, where a conserved insulin/insulin-like growth factor signaling (IIS) pathway and the germline both control lifespan by regulating the subcellular localization of the FoxO transcription factor DAF-16. Although the control of FoxO activity through modulation of its subcellular localization is well established, nuclear translocation of FoxO is not sufficient for full FoxO activation, suggesting that undiscovered inputs regulate FoxO activity after its translocation to the nucleus. We have recently discovered a new conserved pathway, the EAK (enhancer-of-akt-1) pathway, which acts in parallel to the Akt/PKB family of serine-threonine kinases to regulate DAF-16/FoxO activity. Whereas mutation of Akt/PKB promotes the nuclear accumulation of DAF-16/FoxO, mutation of eak genes increases nuclear DAF-16/FoxO activity without influencing DAF-16/FoxO subcellular localization. Thus, EAK proteins regulate the activity of nuclear DAF-16/FoxO. Two EAK proteins, EAK-2/HSD-1 and EAK-7, influence C. elegans lifespan and are conserved in mammals. The discovery of the EAK pathway defines a new conserved FoxO regulatory input and may have implications relevant to aging and the pathogenesis of aging-associated diseases.
Life Sciences Institute, University of Michigan, Ann Arbor, 48109, USA.
Travis W
TW
Williams
Kathleen J
KJ
Dumas
Patrick J
PJ
Hu
D015096:3-Hydroxysteroid Dehydrogenases / Q000235:genetics / Q000378:metabolism; D021581:Active Transport, Cell Nucleus / Q000502:physiology; D000375:Aging / Q000502:physiology; D000818:Animals; D017173:Caenorhabditis elegans / Q000502:physiology*; D029742:Caenorhabditis elegans Proteins / Q000235:genetics / Q000378:metabolism / Q000502:physiology*; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism; D003924:Diabetes Mellitus, Type 2 / Q000209:etiology / Q000378:metabolism; D004194:Disease / Q000209:etiology; D051858:Forkhead Transcription Factors / Q000378:metabolism; D006801:Humans; D008136:Longevity / Q000502:physiology*; D051379:Mice; D008954:Models, Biological; D010024:Osteoporosis / Q000209:etiology / Q000378:metabolism; D010105:Oxygenases / Q000378:metabolism; D051057:Proto-Oncogene Proteins c-akt / Q000235:genetics / Q000378:metabolism; D015398:Signal Transduction / Q000502:physiology; D014157:Transcription Factors / Q000378:metabolism
D029742:Caenorhabditis elegans Proteins; D051858:Forkhead Transcription Factors; D014157:Transcription Factors; C108831:daf-16 protein, C elegans; D003577:Cytochrome P-450 Enzyme System; C486228:DAF-9 protein, C elegans; D015096:3-Hydroxysteroid Dehydrogenases; C510186:DAF-36 protein, C elegans; D010105:Oxygenases; D051057:Proto-Oncogene Proteins c-akt; C494915:akt-1 protein, C elegans